World's Best Scientists 2026 revealed!
Yoshinobu Onuma

Yoshinobu Onuma

D-Index & Metrics

Medicine

D-Index
101
Citations
39889
World Ranking
7943
National Ranking
18

Overview

Yoshinobu Onuma is affiliated with the National University of Ireland, Galway. Their research spans several fields within medicine, with a significant focus on cardiology and cardiovascular medicine, surgery, radiology, nuclear medicine, and pulmonary and respiratory medicine. Their work also includes a smaller contribution to biomedical engineering.

The scientist's publication record features a concentration in the area of coronary interventions and diagnostics, cardiac imaging and diagnostics, antiplatelet therapy and cardiovascular diseases, acute myocardial infarction research, cardiac valve diseases and treatments, cerebrovascular and carotid artery diseases, and peripheral artery disease management.

Frequent venues for their publications include:

  • Journal of the American College of Cardiology
  • JACC: Cardiovascular Interventions
  • European Heart Journal
  • EuroIntervention
  • Cardiovascular Revascularization Medicine

Significant recent papers in their body of work cover various topics within cardiovascular medicine:

  • Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk (2021, New England Journal of Medicine)
  • Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study (2020, European Heart Journal)
  • Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations (2021, Circulation)
  • Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation (2020, The Lancet)
  • Vulnerable plaques and patients: state-of-the-art (2020, European Heart Journal)

Collaboration has been an important aspect of their scientific activity. Frequent co-authors include:

  • Patrick W. Serruys
  • Scot Garg
  • Shigetaka Kageyama
  • Kai Ninomiya
  • Hideyuki Kawashima

The overall research profile of Yoshinobu Onuma reflects a substantial contribution to cardiovascular sciences, evident in a broad range of subjects including interventional procedures, imaging technologies, and therapeutic strategies in cardiology and related disciplines.

Best Publications

  • Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

    Vasim Farooq;David Van Klaveren;Ewout W. Steyerberg;Emanuele Meliga

  • A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

    Patrick W Serruys;John A Ormiston;Yoshinobu Onuma;Evelyn Regar

  • A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

    John A Ormiston;Patrick W Serruys;Evelyn Regar;Dariusz Dudek

  • Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm

  • Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging Outcomes

    Patrick W. Serruys;Yoshinobu Onuma;Dariusz Dudek;Pieter C. Smits

  • Assessment of the SYNTAX score in the Syntax study

    Patrick W. Serruys;Yoshinobu Onuma;Scot Garg;Giovanna Sarno

  • Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

    Hector M. Garcia-Garcia;Eugène P. McFadden;Andrew Farb;Roxana Mehran

  • A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

    Patrick W Serruys;Bernard Chevalier;Dariusz Dudek;Angel Cequier

  • Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

    Patrick W Serruys;Bernard Chevalier;Yohei Sotomi;Angel Cequier

  • Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve.

    Nicolo Piazza;Yoshinobu Onuma;Emile Jesserun;Peter Paul Kint

  • Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.

    Lorenz Räber;Michael Magro;Giulio G. Stefanini;Bindu Kalesan

  • Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.

    Yoshinobu Onuma;Patrick W. Serruys;Laura E.L. Perkins;Takayuki Okamura

  • Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisClinical Perspective

    Patrick W. Serruys;Yoshinobu Onuma;John A. Ormiston;Bernard de Bruyne

  • Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.

    Chao Gao;Yue Cai;Kan Zhang;Lei Zhou

  • Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

    Marco Valgimigli;Enrico Frigoli;Dik Heg;Jan Tijssen

  • From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?

    Patrick W Serruys;Hector M Garcia-Garcia;Yoshinobu Onuma

  • A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.

    Takeshi Kimura;Ken Kozuma;Kengo Tanabe;Sunao Nakamura

  • Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents.

    Soji Nishio;Kunihiko Kosuga;Keiji Igaki;Masaharu Okada

  • Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials

    Christos V Bourantas;Yao-Jun Zhang;Scot Garg;Javaid Iqbal

  • Standardized End Point Definitions for Coronary Intervention Trials

    Hector M. Garcia-Garcia;Eugene P. McFadden;Andrew Farb;Roxana Mehran

Frequent Co-Authors

Patrick W. Serruys
Patrick W. Serruys University of Galway
Hector M. Garcia-Garcia
Hector M. Garcia-Garcia MedStar Washington Hospital Center
Robert-Jan van Geuns
Robert-Jan van Geuns Radboud University
Stephan Windecker
Stephan Windecker University of Bern
Robbert J. de Winter
Robbert J. de Winter University of Amsterdam
Evelyn Regar
Evelyn Regar University of Zurich
Dariusz Dudek
Dariusz Dudek Jagiellonian University
Jan J. Piek
Jan J. Piek University of Amsterdam
Marco Valgimigli
Marco Valgimigli University of Bern
Leif Thuesen
Leif Thuesen Aalborg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA offers diverse study options, including flexible online pathways. For registered nurses looking to advance, online dnp programs allow for doctorate-level training without requiring full-time campus attendance. These programs emphasize clinical expertise and leadership for those aiming to move into advanced practice or administrative roles.

Those seeking to start quickly can consider a 6 month lpn program online. Accelerated LPN courses prepare students for entry-level nursing roles in less than a year, combining flexibility with hands-on support.

If mental healthcare is your specialty, psych np online programs provide specialized training for working nurses to become psychiatric nurse practitioners. These programs combine foundational coursework with advanced mental health topics.

Alternatively, for those interested in management, the cheapest online health science degree options make it easier to enter healthcare administration or public health fields. Affordable tuition and online access mean you can gain the credentials needed to support healthcare organizations efficiently.

Best Scientists Citing Yoshinobu Onuma

Trending Scientists

Recently Published Articles